[1] Ren S, Cai P, Liu Y, et al.Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022, 37(3): 464-470. [2] 张明伟, 汪建超, 王启之, 等. 安徽中南部地区幽门螺杆菌流行病学调查[J]. 中华全科医学, 2020, 18(8): 1395-1398. [3] Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance-from biology to clinical implications[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(9): 613-629. [4] 国家消化系疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组,等. 中国居民家庭幽门螺杆菌感染的防控和管理专家共识(2021年)[J]. 中华消化杂志, 2021, 41(4):221-233. [5] 何权瀛,高莹慧. 关于吸烟问题若干名词定义[J]. 中华结核和呼吸杂志,2009,32(1):26-26. [6] 中国营养学会. 中国居民膳食指南[M]. 拉萨: 西藏人民出版社, 2008:1. [7] Choi IJ, Kim CG, Lee JY, et al.Family history of gastric cancer and Helicobacter pylori treatment[J]. New England J Med, 2020, 382(5): 427-436. [8] Oster P, Vaillant L, Riva E, et al.Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies[J]. Gut, 2022, 71(3): 457-466. [9] 黄小杰, 林晓露, 梁玮, 等. 早期胃食管结合部癌行内镜黏膜下剥离术后非治愈切除的危险因素分析[J]. 江苏大学学报(医学版), 2022, 32(4): 350-354. [10] Megraud F, Bruyndonckx R, Coenen S, et al.Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community[J]. Gut, 2021, 70(10): 1815-1822. [11] 李雅倩, 刘家奇, 朱晓芳, 等. 幽门螺杆菌检测技术研究进展及展望[J]. 微生物学报, 2022, 62(5): 1-14. [12] Ralser A, Dietl A, Jarosch S, et al.Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature[J]. Gur, 2023, 72(7):1258-1270. [13] Mohammadzadeh R, Soleimanpour S, Pishdadian A, et al.Designing and development of epitope-based vaccines against Helicobacter pylori[J]. Crit Rev Microbiol, 2022, 48(4):489-512. [14] Duan M, Liu J, Zuo XL.Dual therapy for Helicobacter pylori infection[J]. Chin Med J, 2022, 48(4):489-512. [15] Ranjbar R, Ebrahimi A, Sahebkar A.Helicobacter pylori Infection: Conventional and molecular strategies for bacterial diagnosis and antibiotic resistance testing[J]. Curr Pharm Biotechnol, 2023, 24(5):647-664. [16] Wang YZ, Chen J, Pei SQ, et al.Treatment strategies and pharmacist-led medication management for Helicobacter pylori infection[J]. Drug Dev Res, 2023, 84(2):326-336. [17] Quach DT, Vilaichone RK, Vu KV, et al.Helicobacter pylori infection and related gastrointestinal diseases in Southeast Asian countries: An expert opinion survey[J]. Asian Pac J Cancer Prev,2018,19(12):3565-3569. [18] Ren S, Cai P, Liu Y, et al.Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol. 2022, 37(3):464-470. [19] Song Z, Chen Y, Lu H, et al.Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study[J]. Helicobacter,2022, 27(3):e12889. [20] Luo Q, Yang H, Hu B.Application of artificial intelligence in the endoscopic diagnosis of early gastric cancer, atrophic gastritis, and Helicobacter pylori infection[J]. J Dig Dis, 2022, 23(12):666-674. [21] Chung WC.Helicobacter pylori eradication reduces risk for recurrence of gastric hyperplastic polyp after endoscopic resection[J]. Korean J Intern Med, 2023, 38(2):141-143. [22] Bucci P, Barbaglia Y, Tedeschi F, et al.Helicobacter pylori infection: A balance between bacteria and host[J]. Rev Argent Microbiol, 2023, 55(1):60-67. [23] Liou JM, Malfertheiner P, Lee YC, et al.Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus[J]. Gut, 2020, 69(12): 2093-2112. [24] 杨玉梅, 刘玉萍, 王林, 等. 成都地区居民幽门螺杆菌感染现状及危险因素分析[J]. 现代预防医学, 2020, 47(17): 3220-3224. [25] Ford AC, Yuan Y, Moayyedi P.Helicobacter pylori eradication therapy to prevent gastric cancer: Systematic review and meta-analysis[J]. Gut, 2020, 69(12): 2113-2121. [26] 吴灵敏. 安顺地区幽门螺旋杆菌感染状况分析[J]. 航空航天医学杂志, 2021, 32(1): 46-48. [27] Ferro A, Morais S, Pelucchi C, et al.Smoking and Helicobacter pylori infection: An individual participant pooled analysis (Stomach Cancer Pooling-StoP Project)[J]. Eur J Cancer Prev, 2019, 28(5):390-396. [28] 薛建华, 俞海萍. 幽门螺杆菌感染的流行现状和危险生活方式研究进展[J]. 健康教育与健康促进, 2021, 16(4):378-382. [29] Charitos IA, D’Agostino D, Topi S, et al. 40 years of Helicobacter pylori: A revolution in biomedical thought[J]. Gastroenterol Insights, 2021, 12(2): 111-135. |